These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

477 related items for PubMed ID: 15515364

  • 41. Basophil activation test for the diagnosis of hymenoptera venom allergy in childhood: a pilot study.
    Ott H, Tenbrock K, Baron J, Merk H, Lehmann S.
    Klin Padiatr; 2011 Jan; 223(1):27-32. PubMed ID: 21271515
    [Abstract] [Full Text] [Related]

  • 42. Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.
    Pereira-Santos MC, Baptista AP, Melo A, Alves RR, Soares RS, Pedro E, Pereira-Barbosa M, Victorino RM, Sousa AE.
    Clin Exp Allergy; 2008 Feb; 38(2):291-7. PubMed ID: 18070166
    [Abstract] [Full Text] [Related]

  • 43. Safety of rush insect venom immunotherapy. The results of a retrospective study in 178 patients.
    Wenzel J, Meissner-Kraemer M, Bauer R, Bieber T, Gerdsen R.
    Allergy; 2003 Nov; 58(11):1176-9. PubMed ID: 14616130
    [Abstract] [Full Text] [Related]

  • 44. Sublingual immunotherapy with venom for patients with Hymenoptera venom allergy.
    Patriarca G, Nucera E, Roncallo C, Aruanno A, Lombardo C, Decinti M, Pascolini L, Milani M, Buonomo A, Schiavino D.
    J Allergy Clin Immunol; 2009 Aug; 124(2):385; author reply 385-6. PubMed ID: 19482349
    [No Abstract] [Full Text] [Related]

  • 45. Standardized extracts. Stinging and biting insects.
    Hoffman DR, Golden DB.
    Clin Rev Allergy; 1987 Feb; 5(1):75-88. PubMed ID: 3548939
    [No Abstract] [Full Text] [Related]

  • 46. [A modified ultra-rush-protocol of allergen immunotherapy in children and adolescents with insect venom allergy].
    Steiss JO, Hüls G, Gortner L, Lindemann H.
    Klin Padiatr; 2004 Feb; 216(2):79-82. PubMed ID: 15106079
    [Abstract] [Full Text] [Related]

  • 47. [Hyposensitization to insect venom allergy: small animals--big effect].
    Reiser-Perić P, Schiller S.
    Pflege Z; 2002 Jul; 55(7):480-4. PubMed ID: 12192781
    [No Abstract] [Full Text] [Related]

  • 48. [Hyper-accelerated immunotherapy with Hymenoptera venoms].
    Sabbah A, Bonneau JC, Drouet M, Le Sellin J.
    Allerg Immunol (Paris); 1987 Apr; 19(4):156-8, 160, 162-3. PubMed ID: 3453132
    [Abstract] [Full Text] [Related]

  • 49. [Hyposensitization in bee and wasp allergy].
    Dahl R, Knudsen N, Andersen P, Geday H, Sørensen HJ, Thormann J.
    Ugeskr Laeger; 1981 Jul 27; 143(31):1963-6. PubMed ID: 7303217
    [No Abstract] [Full Text] [Related]

  • 50. [Bee and wasp venom allergy. Clinical aspects, prevention and therapy].
    Ring J, Lonsdorf G, Schury W, Burg G.
    MMW Munch Med Wochenschr; 1982 Jun 18; 124(24):587-90. PubMed ID: 6810134
    [No Abstract] [Full Text] [Related]

  • 51. Allergen-specific immunotherapy of Hymenoptera venom allergy - also a matter of diagnosis.
    Schiener M, Graessel A, Ollert M, Schmidt-Weber CB, Blank S.
    Hum Vaccin Immunother; 2017 Oct 03; 13(10):2467-2481. PubMed ID: 28604163
    [Abstract] [Full Text] [Related]

  • 52. Sudden death due to stinging insect hypersensitivity: postmortem demonstration of IgE antivenom antibodies in a fatal case.
    Schwartz HJ, Yunginger JW, Teigland JD, Sutheimer C, Hiss Y.
    Am J Clin Pathol; 1984 Jun 03; 81(6):794-5. PubMed ID: 6731361
    [Abstract] [Full Text] [Related]

  • 53. [Hyposensitization in wasp venom and bee venom allergy].
    Forck G.
    Med Monatsschr Pharm; 1985 Apr 03; 8(4):107-12. PubMed ID: 4000054
    [No Abstract] [Full Text] [Related]

  • 54. Allergen specific immunotherapy is safe and effective in patients with systemic mastocytosis and Hymenoptera allergy.
    Bonadonna P, Zanotti R, Caruso B, Castellani L, Perbellini O, Colarossi S, Chilosi M, Dama A, Schiappoli M, Pizzolo G, Senna G, Passalacqua G.
    J Allergy Clin Immunol; 2008 Jan 03; 121(1):256-7. PubMed ID: 18206512
    [No Abstract] [Full Text] [Related]

  • 55. Continuous immunotherapy for hymenoptera venom allergy using six month intervals.
    Baenkler HW, Meusser-Storm S, Eger G.
    Allergol Immunopathol (Madr); 2005 Jan 03; 33(1):7-14. PubMed ID: 15777517
    [Abstract] [Full Text] [Related]

  • 56. Hymenoptera venom immunotherapy: Past, present, and future.
    Oppenheimer J, Golden DBK.
    Ann Allergy Asthma Immunol; 2018 Sep 03; 121(3):276-277. PubMed ID: 29909053
    [No Abstract] [Full Text] [Related]

  • 57. Safety of hymenoptera venom immunotherapy: a systematic review.
    Incorvaia C, Frati F, Dell'Albani I, Robino A, Cattaneo E, Mauro M, David M, Qualizza R, Pastorello E.
    Expert Opin Pharmacother; 2011 Nov 03; 12(16):2527-32. PubMed ID: 21883032
    [Abstract] [Full Text] [Related]

  • 58. Agreement of skin test with IL-4 production and CD40L expression by T cells upon immunotherapy of subjects with systemic reactions to Hymenoptera stings.
    Urra JM, Cabrera CM, Alfaya T, Feo-Brito F.
    Mol Immunol; 2016 Feb 03; 70():134-9. PubMed ID: 26774053
    [Abstract] [Full Text] [Related]

  • 59. Systemic and local reactions of bee venom immunotherapy in Iran.
    Bemanian MH, Farhoudi A, Pourpak Z, Gharagozlou M, Movahedi M, Nabavi M, Mozafari H, Mohammadzadeh I, Chavoshzadeh Z, Shirkhoda Z.
    Iran J Allergy Asthma Immunol; 2007 Dec 03; 6(4):203-6. PubMed ID: 18094443
    [Abstract] [Full Text] [Related]

  • 60. [Allergy to bee and wasp venoms. Reaction forms, diagnosis and treatment].
    Dahl R, Knudsen N.
    Ugeskr Laeger; 1981 Jul 27; 143(31):1960-2. PubMed ID: 7303216
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.